Therapure Biomanufacturing

Passion for your process, product and patients

Therapure Biomanufacturing is a global contract development and manufacturing organization (CDMO)—your source for integrated biologics CDMO services. Our scientific and manufacturing expertise, as well as our flexible state-of-the-art cGMP facility, provides you with optimal biomanufacturing solutions.

What can you expect
as a Therapure Biomanufacturing client:

Partnership—we work with you to accomplish innovative and efficient solutions at every development stage of your biopharmaceutical in order to maximize protein expression and yields for clinical and commercial manufacturing.

Support—dedicated project managers are a key point of contact from the technical transfer stage to project completion for preclinical, clinical or commercial production. Our team, led by your project manager, focuses on applying scheduling, risk-management and manufacturing improvements.

Facility—comprising 136,000 ft2 (12,800 m2) that includes cGMP manufacturing, research and quality control laboratories, all built to FDA, EMA and Health Canada standards.

Expertise—we apply an intimate understanding of the science, the cGMP biomanufacturing process and the regulatory requirements to the manufacturing of biologic products.

Capabilities—we employ technological, scientific and manufacturing expertise to meet your clinical and commercial development and cGMP manufacturing needs, including the following:

Therapure CDMO is now a part of Resilience!

The CDMO assets of Therapure Biopharma Inc have been acquired by Resilience Biotechnologies, Inc., a wholly owned Canadian subsidiary of National Resilience, Inc. (Resilience), a U.S. based biopharmaceutical manufacturing and technology company.


We remain committed to supporting you as Resilience Biotechnologies Inc.


For more information about Resilience, please visit: https://resilience.com